A detailed history of Stableford Capital Ii LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Stableford Capital Ii LLC holds 4,990 shares of ABBV stock, worth $823,300. This represents 0.39% of its overall portfolio holdings.

Number of Shares
4,990
Previous 5,264 5.21%
Holding current value
$823,300
Previous $902,000 9.2%
% of portfolio
0.39%
Previous 0.35%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

SELL
$163.84 - $199.33 $44,892 - $54,616
-274 Reduced 5.21%
4,990 $985,000
Q2 2024

Jul 23, 2024

BUY
$154.79 - $180.76 $34,982 - $40,851
226 Added 4.49%
5,264 $902,000
Q1 2024

Apr 09, 2024

SELL
$159.82 - $182.1 $52,900 - $60,275
-331 Reduced 6.17%
5,038 $917,000
Q4 2023

Jan 12, 2024

SELL
$137.6 - $154.97 $19,264 - $21,695
-140 Reduced 2.54%
5,369 $832,000
Q3 2023

Oct 30, 2023

SELL
$133.59 - $154.65 $86,566 - $100,213
-648 Reduced 10.52%
5,509 $821,000
Q2 2023

Aug 11, 2023

BUY
$132.51 - $164.9 $815,864 - $1.02 Million
6,157 New
6,157 $829,000
Q4 2022

Jan 10, 2023

SELL
$138.31 - $165.87 $72,889 - $87,413
-527 Reduced 9.96%
4,766 $770 Million
Q3 2022

Oct 25, 2022

BUY
$134.21 - $153.93 $29,526 - $33,864
220 Added 4.34%
5,293 $778,000
Q2 2022

Oct 25, 2022

SELL
$137.62 - $174.96 $30,276 - $38,491
-220 Reduced 4.16%
5,073 $700,000
Q2 2022

Aug 08, 2022

SELL
$137.62 - $174.96 $322,994 - $410,631
-2,347 Reduced 31.63%
5,073 $700,000
Q1 2022

Apr 11, 2022

BUY
$131.98 - $163.75 $979,291 - $1.22 Million
7,420 New
7,420 $1.29 Million
Q1 2019

Feb 10, 2021

SELL
$77.14 - $90.79 $273,152 - $321,487
-3,541 Closed
0 $0
Q4 2018

Feb 12, 2021

SELL
$77.85 - $96.01 $102,995 - $127,021
-1,323 Reduced 27.2%
3,541 $326,000
Q3 2018

Feb 10, 2021

SELL
$88.91 - $98.84 $4,267 - $4,744
-48 Reduced 0.98%
4,864 $460,000
Q2 2018

Feb 10, 2021

BUY
$89.78 - $106.23 $6,913 - $8,179
77 Added 1.59%
4,912 $455,000
Q1 2018

Feb 10, 2021

SELL
$92.01 - $123.21 $3,036 - $4,065
-33 Reduced 0.68%
4,835 $458,000
Q4 2017

Feb 10, 2021

SELL
$89.56 - $98.21 $9,941 - $10,901
-111 Reduced 2.23%
4,868 $471,000
Q2 2017

Feb 10, 2021

BUY
N/A
4,979
4,979 $442,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $292B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Stableford Capital Ii LLC Portfolio

Follow Stableford Capital Ii LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stableford Capital Ii LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stableford Capital Ii LLC with notifications on news.